Iran vs Lebanon: Cause of death, by non-communicable diseases, ages 5-14, female
Iran
47.1%
in 2021
Lebanon
46.2%
in 2021
Iran rank
69th
Lebanon rank
71st
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Iran
- Lebanon
How they compare
Iran currently reports 47.1% against 46.2% in Lebanon, a difference of 0.9%.
Across all 6 years both countries report, Iran has been ahead every year.
Iran ranks 69th and Lebanon ranks 71st of 184 countries.
Iran has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iran | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 43.0% | 35.8% | 7.2% | Iran |
| 2010s | 48.7% | 39.2% | 9.5% | Iran |
| 2020s | 48.5% | 44.7% | 3.8% | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Iran or Lebanon?
- Iran, at 47.1% against 46.2% in Lebanon as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Iran and Lebanon?
- 0.9%, with Iran ahead.
- How many years of comparable data are there for Iran and Lebanon?
- 6 years are reported by both, from 2000 to 2021.
- How do Iran and Lebanon rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Iran ranks 69th and Lebanon ranks 71st of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.